3 completed, 1 active not recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow CORT113176: new trials by email Literature Review of CORT113176 trials Research Report on CORT113176
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant Dazucorilant - Hepatic Impairment | Phase 1 | Completed | Corcept Therapeutics | 19 | 2024-10-08 | 2025-04-15 |
| Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants Dazucorilant, Itraconazole - Healthy Adults | Phase 1 | Completed | Corcept Therapeutics | 21 | 2024-05-31 | 2025-07-01 |
| Dazucorilant in Patients With Amyotrophic Lateral Sclerosis Dazucorilant 300 mg, Dazucorilant 150 mg, Placebo - Amyotrophic Lateral Sclerosis | Phase 2 | Active not recruiting | Corcept Therapeutics | 279 | 2022-11-15 | 2026-09-24 |
| Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants CORT113176, Placebo matching CORT113176 - Healthy Adults | Phase 1 | Completed | Corcept Therapeutics | 16 | 2021-07-13 | 2021-10-11 |
Amyotrophic Lateral Sclerosis (1)
United States (3) · Netherlands (2) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Poland (1) · Spain (1) · United Kingdom (1)
Hazel Hunt, Ph.D. (1) · Jeevan Kunta, PhD (1) · Joseph Custodio, PhD (1) · Sophia Majeed, PharmD, PhD (1)